Loading...

You're on the old version of Simply Wall St. We will no longer be supporting this site, so we recommend you switch to our brand new platform.

Shop Apotheke Europe

BATS-CHIXE:SAED
Snowflake Description

Adequate balance sheet with limited growth.

The Snowflake is generated from 30 checks in 5 different areas, read more below.
SAED
BATS-CHIXE
€916M
Market Cap
  1. Home
  2. GB
  3. Retail
Company description

Shop Apotheke Europe N.V. owns and operates online pharmacies in Germany, Austria, Switzerland, Belgium, the Netherlands, France, Italy, and Spain. The last earnings update was 21 days ago. More info.


Add to Portfolio Compare Print
  • Shop Apotheke Europe has significant price volatility in the past 3 months.
SAED Share Price and Events
7 Day Returns
33.5%
BATS-CHIXE:SAED
3.3%
GB Online Retail
0.1%
GB Market
1 Year Returns
69.8%
BATS-CHIXE:SAED
-8.7%
GB Online Retail
-23.6%
GB Market
SAED Shareholder Return
  7 Day 30 Day 90 Day 1 Year 3 Year 5 Year
Shop Apotheke Europe (SAED) 33.5% 31.9% 56.9% 69.8% - -
GB Online Retail 3.3% -6.4% -13.9% -8.7% 37% 64.4%
GB Market 0.1% -15.5% -27% -23.6% -24.3% -23.5%
1 Year Return vs Industry and Market
  • SAED outperformed the Online Retail industry which returned -8.7% over the past year.
  • SAED outperformed the Market in United Kingdom of Great Britain and Northern Ireland which returned -23.6% over the past year.
Price Volatility
SAED
Industry
5yr Volatility vs Market
Related Companies

Value

 Is Shop Apotheke Europe undervalued based on future cash flows and its price relative to the stock market?

Value is all about what a company is worth versus what price it is available for. If you went into a grocery store and all the bananas were on sale at half price, they could be considered undervalued.
INTRINSIC VALUE BASED ON FUTURE CASH FLOWS
  • It is not possible to calculate the future cash flow value for Shop Apotheke Europe. This is due to cash flow or dividend data being unavailable. The share price is €67.4.
PRICE RELATIVE TO MARKET
We can also value a company based on what the stock market is willing to pay for it. This is similar to the price of fruit (e.g. Mangoes or Avocados) increasing when they are out of season, or how much your home is worth.

The amount the stock market is willing to pay for Shop Apotheke Europe's earnings, growth and assets is considered below, and whether this is a fair price.
Price based on past earnings
Are Shop Apotheke Europe's earnings available for a low price, and how does this compare to other companies in the same industry?
Raw Data
BATS-CHIXE:SAED PE (Price to Earnings) Ratio Data Sources
Data Point Source Value
Earnings Per Share * Company Filings (2019-12-31) in EUR €-2.78
XTRA:SAE Share Price ** XTRA (2020-04-06) in EUR €63.3
United Kingdom of Great Britain and Northern Ireland Online Retail Industry PE Ratio Median Figure of 8 Publicly-Listed Online Retail Companies 16.52x
United Kingdom of Great Britain and Northern Ireland Market PE Ratio Median Figure of 748 Publicly-Listed Companies 12.61x

* Trailing twelve months (TTM) annual GAAP earnings per share excluding extraordinary items.

** Primary Listing of Shop Apotheke Europe.

BATS-CHIXE:SAED PE (Price to Earnings) Ratio Calculation
Calculation Outcome
PE Ratio

= XTRA:SAE Share Price ÷ EPS (both in EUR)

= 63.3 ÷ -2.78

-22.8x

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Shop Apotheke Europe is loss making, we can't compare its value to the GB Online Retail industry average.
  • Shop Apotheke Europe is loss making, we can't compare the value of its earnings to the United Kingdom of Great Britain and Northern Ireland market.
Price based on expected Growth
Does Shop Apotheke Europe's expected growth come at a high price?
Raw Data
BATS-CHIXE:SAED PEG (Price to Earnings to Growth) Ratio Data Sources
Data Point Source Value
PE Ratio See PE Ratio Section -22.8x
Net Income Annual Growth Rate See Future Growth Section.
Line of Best Fit* through Consensus Estimate Earnings of 5 Analysts
52.3%per year
United Kingdom of Great Britain and Northern Ireland Online Retail Industry PEG Ratio Median Figure of 7 Publicly-Listed Online Retail Companies 1.2x
United Kingdom of Great Britain and Northern Ireland Market PEG Ratio Median Figure of 517 Publicly-Listed Companies 0.99x

*Line of best fit is calculated by linear regression .

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Unable to calculate PEG ratio for Shop Apotheke Europe, we can't assess if its growth is good value.
Price based on value of assets
What value do investors place on Shop Apotheke Europe's assets?
Raw Data
BATS-CHIXE:SAED PB (Price to Book) Ratio Data Sources
Data Point Source Value
Book Value per Share Company Filings (2019-12-31) in EUR €17.29
XTRA:SAE Share Price * XTRA (2020-04-06) in EUR €63.3
United Kingdom of Great Britain and Northern Ireland Online Retail Industry PB Ratio Median Figure of 16 Publicly-Listed Online Retail Companies 2.19x
United Kingdom of Great Britain and Northern Ireland Market PB Ratio Median Figure of 1,323 Publicly-Listed Companies 1.11x
BATS-CHIXE:SAED PB (Price to Book) Ratio Calculation
Calculation Outcome
PB Ratio

= XTRA:SAE Share Price ÷ Book Value per Share (both in EUR)

= 63.3 ÷ 17.29

3.66x

* Primary Listing of Shop Apotheke Europe.

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Shop Apotheke Europe is overvalued based on assets compared to the GB Online Retail industry average.
X
Value checks
We assess Shop Apotheke Europe's value by looking at:
  1. Is the discounted cash flow value less than 20%, or 40% of the share price? (2 checks) ( Click here or on bar chart for details of DCF calculation. )
  2. Is the PE ratio less than the market average, and/ or less than the Online Retail industry average (and greater than 0)? (2 checks)
  3. Is the PEG ratio within a reasonable range (0 to 1)? (1 check)
  4. Is the PB ratio less than the Online Retail industry average (and greater than 0)? (1 check)
  5. Shop Apotheke Europe has a total score of 0/6, see the detailed checks below.

    Note: We use GAAP Earnings per Share in all our calculations including PE and PEG Ratio.

    Full details on the Value part of the Simply Wall St company analysis model.

Future Performance

 How is Shop Apotheke Europe expected to perform in the next 1 to 3 years based on estimates from 5 analysts?

The future performance of a company is measured in the same way as past performance, by looking at estimated growth and how much profit it is expected to make.

Future estimates come from professional analysts. Just like forecasting the weather, they don’t always get it right!
Annual Growth Rate
52.3%
Expected annual growth in earnings.
Earnings growth vs Low Risk Savings
Is Shop Apotheke Europe expected to grow at an attractive rate?
  • Unable to compare Shop Apotheke Europe's earnings growth to the low risk savings rate as it is expected to be loss making during the next 1-3 years.
Growth vs Market Checks
  • Unable to compare Shop Apotheke Europe's earnings growth to the United Kingdom of Great Britain and Northern Ireland market average as it is expected to be loss making during the next 1-3 years.
  • Shop Apotheke Europe's revenue growth is expected to exceed the United Kingdom of Great Britain and Northern Ireland market average.
Annual Growth Rates Comparison
Raw Data
BATS-CHIXE:SAED Future Growth Rates Data Sources
Data Point Source Value (per year)
BATS-CHIXE:SAED Future Earnings Growth Rate Line of Best Fit* through Consensus Estimate Earnings of 5 Analysts 52.3%
BATS-CHIXE:SAED Future Revenue Growth Rate Line of Best Fit* through Consensus Estimate Revenue of 5 Analysts 20.1%
United Kingdom of Great Britain and Northern Ireland Online Retail Industry Earnings Growth Rate Market Cap Weighted Average 43.2%
United Kingdom of Great Britain and Northern Ireland Online Retail Industry Revenue Growth Rate Market Cap Weighted Average 12.8%
United Kingdom of Great Britain and Northern Ireland Market Earnings Growth Rate Market Cap Weighted Average 15.5%
United Kingdom of Great Britain and Northern Ireland Market Revenue Growth Rate Market Cap Weighted Average 2.5%

*Line of best fit is calculated by linear regression .

Industry and Market average data is calculated daily.

Learn more about our growth rate calculations in Simply Wall St’s analysis model.

Analysts growth expectations
Raw Data
BATS-CHIXE:SAED Analysts Growth Expectations Data Sources
Data Point Source Value
Past Financials Company Filings (3 months ago) See Below
Future Estimates Average of up to 5 Analyst Estimates (S&P Global) See Below
All numbers in EUR Millions and using Trailing twelve months (TTM) annual period rather than quarterly.
BATS-CHIXE:SAED Future Estimates Data
Date (Data in EUR Millions) Revenue Cash Flow Net Income * Avg. No. Analysts
2023-12-31 1,432 1
2022-12-31 1,430 3 -3 4
2021-12-31 1,120 -6 -17 5
2020-12-31 877 -24 -27 4
2020-04-07
BATS-CHIXE:SAED Past Financials Data
Date (Data in EUR Millions) Revenue Cash Flow Net Income *
2019-12-31 701 -30 -36
2019-09-30 660 -20 -41
2019-06-30 621 -19 -40
2019-03-31 584 -35 -40
2018-12-31 540 -15 -34
2018-09-30 481 -31 -31
2018-06-30 415 -24 -28
2018-03-31 351 -17 -24
2017-12-31 284 -23 -21
2017-09-30 244 -11 -22
2017-06-30 222 -16 -20
2017-03-31 200 -14 -20

*GAAP earnings excluding extraordinary items.

Super high growth metrics
High Growth Checks
  • Shop Apotheke Europe is not considered high growth as it is expected to be loss making for the next 1-3 years.
  • Shop Apotheke Europe's revenue is expected to grow significantly at over 20% yearly.
Past and Future Earnings per Share
The accuracy of the analysts who estimate the future performance data can be gauged below. We look back 3 years and see if they were any good at predicting what actually occurred. We also show the highest and lowest estimates looking forward to see if there is a wide range.
Raw Data
BATS-CHIXE:SAED Past and Future Earnings per Share
Data Point Source Value
Past Financials Company Filings (3 months ago) See Below
Future Estimates Average of up to 5 Analyst Estimates (S&P Global) See Below

All data from Shop Apotheke Europe Company Filings, last reported 3 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

BATS-CHIXE:SAED Future Estimates Data
Date (Data in EUR Millions) EPS * EPS High Estimate EPS Low Estimate Avg. No. Analysts
2023-12-31
2022-12-31 -0.20 0.89 -1.33 4.00
2021-12-31 -1.29 -0.83 -1.76 5.00
2020-12-31 -2.03 -1.94 -2.18 4.00
2020-04-07
BATS-CHIXE:SAED Past Financials Data
Date (Data in EUR Millions) EPS *
2019-12-31 -2.78
2019-09-30
2019-06-30 -3.24
2019-03-31
2018-12-31 -2.79
2018-09-30
2018-06-30 -2.57
2018-03-31
2017-12-31 -2.25
2017-09-30 -1.86
2017-06-30 -2.53
2017-03-31 -2.23

*GAAP earnings excluding extraordinary items.

Performance in 3 years
In the same way as past performance we look at the future estimated return (profit) compared to the available funds. We do this looking forward 3 years.
  • Unable to establish if Shop Apotheke Europe will efficiently use shareholders’ funds in the future (Return on Equity greater than 20%) as it is not expected to be profitable.
X
Future performance checks
We assess Shop Apotheke Europe's future performance by looking at:
  1. Is the annual earnings growth rate expected to beat the low risk savings rate, plus a premium to keep pace with inflation?
  2. Is the annual earnings growth rate expected to beat the average growth rate in earnings of the United Kingdom of Great Britain and Northern Ireland market? (1 check)
  3. Is the annual revenue growth rate expected to beat the average growth rate in revenue of the United Kingdom of Great Britain and Northern Ireland market? (1 check)
  4. Is the annual earnings growth rate expected to be above 20%? (1 check)
  5. Is the annual revenue growth rate expected to be above 20%? (1 check)
  6. Is the Return on Equity in 3 years expected to be over 20%? (1 check)
Some of the above checks will fail if the company is expected to be loss making in the relevant year.
Shop Apotheke Europe has a total score of 2/6, see the detailed checks below.

Note 1: We use GAAP Net Income Excluding Exceptional Items for our Earnings in all our calculations.

Full details on the Future part of the Simply Wall St company analysis model.

Past Performance

  How has Shop Apotheke Europe performed over the past 5 years?

The past performance of a company can be measured by how much growth it has experienced and how much profit it makes relative to the funds and assets it has available.
Past earnings growth
Below we compare Shop Apotheke Europe's growth in the last year to its industry (Online Retail).
Past Earnings growth analysis
We also check if the company has grown in the past 5 years, and whether it has maintained that growth in the year.
  • Shop Apotheke Europe does not make a profit and their year on year earnings growth rate was negative over the past 5 years.
  • Unable to compare Shop Apotheke Europe's 1-year earnings growth to the 5-year average as it is not currently profitable.
  • Unable to compare Shop Apotheke Europe's 1-year growth to the GB Online Retail industry average as it is not currently profitable.
Earnings and Revenue History
Shop Apotheke Europe's revenue and profit over the past 5 years is shown below, any years where they have experienced a loss will show up in red.
Raw Data

All data from Shop Apotheke Europe Company Filings, last reported 3 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

BATS-CHIXE:SAED Past Revenue, Cash Flow and Net Income Data
Date (Data in EUR Millions) Revenue Net Income * G+A Expenses R&D Expenses
2019-12-31 701.01 -36.27 171.86
2019-09-30 660.38 -41.09 157.24
2019-06-30 620.76 -40.01 148.85
2019-03-31 583.69 -40.22 139.27
2018-12-31 539.71 -33.61 127.19
2018-09-30 481.31 -31.30 115.74
2018-06-30 414.52 -28.16 104.04
2018-03-31 350.88 -24.03 92.03
2017-12-31 283.99 -21.36 79.80
2017-09-30 243.87 -22.40 69.80
2017-06-30 221.94 -20.35 62.88
2017-03-31 200.16 -20.26 57.07
2016-12-31 177.39 -18.45 50.13
2016-09-30 159.22 -12.90 44.68
2016-06-30 147.21 -12.84 42.61
2016-03-31 136.32 -12.21 39.73
2015-12-31 125.58 -10.55 35.87
2014-12-31 84.67 -5.04 23.01
2013-12-31 55.29 -2.83 15.30

*GAAP earnings excluding extraordinary items.

Performance last year
We want to ensure a company is making the most of what it has available. This is done by comparing the return (profit) to a company's available funds, assets and capital.
  • It is difficult to establish if Shop Apotheke Europe has efficiently used shareholders’ funds last year (Return on Equity greater than 20%) as it is loss-making.
  • It is difficult to establish if Shop Apotheke Europe has efficiently used its assets last year compared to the GB Online Retail industry average (Return on Assets) as it is loss-making.
  • It is difficult to establish if Shop Apotheke Europe improved its use of capital last year versus 3 years ago (Return on Capital Employed) as it is currently loss-making.
X
Past performance checks
We assess Shop Apotheke Europe's performance over the past 5 years by checking for:
  1. Has earnings increased in past 5 years? (1 check)
  2. Has the earnings growth in the last year exceeded that of the Online Retail industry? (1 check)
  3. Is the recent earnings growth over the last year higher than the average annual growth over the past 5 years? (1 check)
  4. Is the Return on Equity (ROE) higher than 20%? (1 check)
  5. Is the Return on Assets (ROA) above industry average? (1 check)
  6. Has the Return on Capital Employed (ROCE) increased from 3 years ago? (1 check)
The above checks will fail if the company has reported a loss in the most recent earnings report. Some checks require at least 3 or 5 years worth of data.
Shop Apotheke Europe has a total score of 0/6, see the detailed checks below.

Note: We use GAAP Net Income excluding extraordinary items in all our calculations.

Full details on the Past part of the Simply Wall St company analysis model.

Health

 How is Shop Apotheke Europe's financial health and their level of debt?

A company's financial position is much like your own financial position, it includes everything you own (assets) and owe (liabilities).

The boxes below represent the relative size of what makes up Shop Apotheke Europe's finances.

The net worth of a company is the difference between its assets and liabilities.
Net Worth
  • Shop Apotheke Europe is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
  • Shop Apotheke Europe's cash and other short term assets cover its long term commitments.
Balance sheet
This treemap shows a more detailed breakdown of Shop Apotheke Europe's finances. If any of them are yellow this indicates they may be out of proportion and red means they relate to one of the checks below.
Assets
Liabilities and shares
The 'shares' portion represents any funds contributed by the owners (shareholders) and any profits.
  • Low level of unsold assets.
  • Debt is covered by short term assets, assets are 1.5x debt.
Historical Debt
Nearly all companies have debt. Debt in itself isn’t bad, however if the debt is too high, or the company can’t afford to pay the interest on its debts this may have impacts in the future.

The graphic below shows equity (available funds) and debt, we ideally want to see the red area (debt) decreasing.

If there is any debt we look at the companies capability to repay it, and whether the level has increased over the past 5 years.
Raw Data

All data from Shop Apotheke Europe Company Filings, last reported 3 months ago.

BATS-CHIXE:SAED Past Debt and Equity Data
Date (Data in EUR Millions) Total Equity Total Debt Cash & Short Term Investments
2019-12-31 232.76 142.80 113.23
2019-09-30 237.85 152.25 148.89
2019-06-30 246.04 149.07 158.13
2019-03-31 199.95 87.53 50.58
2018-12-31 213.98 81.54 58.76
2018-09-30 224.12 4.75 79.79
2018-06-30 228.48 4.77 92.41
2018-03-31 230.86 4.23 32.15
2017-12-31 238.97 7.30 28.29
2017-09-30 80.66 0.00 51.54
2017-06-30 85.12 0.00 53.04
2017-03-31 87.81 0.00 54.92
2016-12-31 93.25 0.28 58.50
2016-09-30 8.05 20.07 6.27
2016-06-30 6.24 19.72 10.46
2016-03-31 2.46 19.00 3.53
2015-12-31 2.46 19.00 3.53
2014-12-31 20.06 0.00 0.30
2013-12-31 18.08 0.00 0.09
  • Shop Apotheke Europe's level of debt (61.3%) compared to net worth is high (greater than 40%).
  • The level of debt compared to net worth has increased over the past 5 years (0.3% vs 61.3% today).
CASH RUNWAY ANALYSIS

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

  • Shop Apotheke Europe has sufficient cash runway for 2.5 years based on current free cash flow.
  • Shop Apotheke Europe has sufficient cash runway for more than 3 years if free cash flow continues to grow at historical rates of 28.2% each year.
X
Financial health checks
We assess Shop Apotheke Europe's financial health by checking for:
  1. Are short term assets greater than short term liabilities? (1 check)
  2. Are short term assets greater than long term liabilities? (1 check)
  3. Has the debt to equity ratio increased in the past 5 years? (1 check)
  4. Is the debt to equity ratio over 40%? (1 check)
  5. Is the debt covered by operating cash flow? (1 check)
  6. Are earnings greater than 5x the interest on debt (if company pays interest at all)? (1 check)
  7. Shop Apotheke Europe has a total score of 4/6, see the detailed checks below.
For companies that are loss making and have been so on average in the past we replace the last 2 checks with:
  1. Does cash and short term investments cover stable operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)
  2. Does cash and short term investments cover growing operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)


Full details on the Health part of the Simply Wall St company analysis model.

Dividends

 What is Shop Apotheke Europe's current dividend yield, its reliability and sustainability?

Dividends are regular cash payments to you from the company, similar to a bank paying you interest on a savings account.
Annual Dividend Income
Dividend payments
0%
Current annual income from Shop Apotheke Europe dividends. Estimated to be 0% next year.
If you bought €2,000 of Shop Apotheke Europe shares you are expected to receive €0 in your first year as a dividend.
Dividend Amount
Here we look how much dividend is being paid, if any. Is it above what you can get in a savings account? It is up there with the best dividend paying companies?
  • Unable to evaluate Shop Apotheke Europe's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.
  • Unable to evaluate Shop Apotheke Europe's dividend against the top 25% market benchmark as the company has not reported any payouts.
Annualized Historical and Future Dividends
It is important to see if the dividend for a company is stable, and not wildly increasing/decreasing each year. This graph shows you the historical rate to count toward your assessment of the stock.

We also check to see if the dividend has increased in the past 10 years.
Raw Data
BATS-CHIXE:SAED Annualized Past and Future Dividends
Data Point Source Value
Past Annualized Dividend Yield S&P Global Market Data See Below
Past Dividends per Share Company Filings/ Annualized Dividend Payments See Below
Future Dividends per Share Estimates Average of up to 5 Analyst Estimates (S&P Global) See Below
Europe Online Retail Industry Average Dividend Yield Market Cap Weighted Average of 9 Stocks 4.2%
United Kingdom of Great Britain and Northern Ireland Market Average Dividend Yield Market Cap Weighted Average of 588 Stocks 5.6%
United Kingdom of Great Britain and Northern Ireland Minimum Threshold Dividend Yield 10th Percentile 1.3%
United Kingdom of Great Britain and Northern Ireland Bottom 25% Dividend Yield 25th Percentile 2.6%
United Kingdom of Great Britain and Northern Ireland Top 25% Dividend Yield 75th Percentile 7.1%

Industry and Market average data is calculated daily.

Note all dividend per share amounts are annualized and not quarterly or other period.

BATS-CHIXE:SAED Future Dividends Estimate Data
Date (Data in €) Dividend per Share (annual) Avg. No. Analysts
2023-12-31 0.00 1.00
2022-12-31 0.00 1.00
2021-12-31 0.00 2.00
2020-12-31 0.00 2.00
2020-04-07

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Unable to perform a dividend volatility check as Shop Apotheke Europe has not reported any payouts.
  • Unable to verify if Shop Apotheke Europe's dividend has been increasing as the company has not reported any payouts.
Current Payout to shareholders
What portion of Shop Apotheke Europe's earnings are paid to the shareholders as a dividend.
  • Unable to calculate sustainability of dividends as Shop Apotheke Europe has not reported any payouts.
Future Payout to shareholders
  • No need to calculate the sustainability of Shop Apotheke Europe's dividends in 3 years as they are not expected to pay a notable one for United Kingdom of Great Britain and Northern Ireland.
X
Income/ dividend checks
We assess Shop Apotheke Europe's dividend by checking for:
  1. Firstly is the company paying a notable dividend (greater than 1.3%) - if not then the rest of the checks are ignored.
  2. Is current dividend yield above the bottom 25% of dividend payers? (1 check)
  3. Is current dividend yield above the top 25% of dividend payers? (1 check)
  4. Have they paid a dividend for 10 years, and during this period has the dividend been volatile (drop of more than 25%)? (1 check)
  5. If they have paid a dividend for 10 years has it increased in this time? (1 check)
  6. How sustainable is the dividend, can Shop Apotheke Europe afford to pay it from its earnings today and in 3 years (Payout ratio less than 90%)? (2 checks)
  7. Shop Apotheke Europe has a total score of 0/6, see the detailed checks below.


Full details on the Dividends part of the Simply Wall St company analysis model.

Management

 What is the CEO of Shop Apotheke Europe's salary, the management and board of directors tenure and is there insider trading?

Management is one of the most important areas of a company. We look at unreasonable CEO compensation, how long the team and board of directors have been around for and insider trading.
CEO
Stefan Feltens
COMPENSATION €156,720
AGE 54
TENURE AS CEO 1.3 years
CEO Bio

Mr. Stefan Feltens has been the Chairman of Managing Board and Chief Executive Officer at Shop Apotheke Europe N.V., since January 1, 2019 and served as its Manager of Purchasing and Human Resources since September 17, 2018 until January 1, 2019. Mr. Feltens served as Chief Executive Officer at AWD.pharma GmbH & Co. KG. He served as Vice President and Chief Financial Officer at Teva Canada Limited. He has many years of international experience in the pharmaceutical industry.

CEO Compensation
  • Insufficient data for Stefan to compare compensation growth.
  • Stefan's remuneration is lower than average for companies of similar size in United Kingdom of Great Britain and Northern Ireland.
Management Team Tenure

Average tenure and age of the Shop Apotheke Europe management team in years:

1.3
Average Tenure
46
Average Age
  • The average tenure for the Shop Apotheke Europe management team is less than 2 years, this suggests a new team.
Management Team

Stefan Feltens

TITLE
Chairman of the Managing Board & CEO
COMPENSATION
€157K
AGE
54
TENURE
1.3 yrs

Stephan Weber

TITLE
Co-Founder
COMPENSATION
€175K
AGE
40

Marc Fischer

TITLE
Co-Founder
COMPENSATION
€174K
AGE
44

Theresa Holler

TITLE
COO & Member of the Managing Board
COMPENSATION
€180K
AGE
46
TENURE
4.3 yrs

Jasper Eenhorst

TITLE
CFO & Member of Management Board
AGE
46
TENURE
0.2 yrs

Patrick Schneider

TITLE
Chief Sales Officer

Beate Krosch

TITLE
Director of Human Resources

Nana Lohmanns

TITLE
Chief E-Health Officer

Dirk Bruse

TITLE
Chief Brand Officer

Jens Wolfgarten

TITLE
Chief Product Officer - Retail
Board of Directors Tenure

Average tenure and age of the Shop Apotheke Europe board of directors in years:

4.3
Average Tenure
50.5
Average Age
  • The tenure for the Shop Apotheke Europe board of directors is about average.
Board of Directors

Jan Pyttel

TITLE
Chairman of the Supervisory Board
COMPENSATION
€30K
AGE
54
TENURE
4.3 yrs

Björn Söder

TITLE
Vice Chairman of the Supervisory Board
COMPENSATION
€20K
AGE
47
TENURE
4.3 yrs

Frank Köhler

TITLE
Member of Supervisory Board
COMPENSATION
€20K
AGE
55
TENURE
4.3 yrs

Jérôme Cochet

TITLE
Member of Supervisory Board
COMPENSATION
€20K
AGE
41
TENURE
4.3 yrs
Who owns this company?
Recent Insider Trading
  • No 3 month open market individual insider trading information.
Recent Insider Transactions
Announced Type Name Entity Role Start End Shares Max Price (€) Value (€)
X
Management checks
We assess Shop Apotheke Europe's management by checking for:
  1. Is the CEO's compensation unreasonable compared to market cap? (1 check)
  2. Has the CEO's compensation increased more than 20% whilst the EPS is down more then 20%? (1 check)
  3. Is the average tenure of the management team less than 2 years? (1 check)
  4. Is the average tenure of the board of directors team less than 3 years? (1 check)
  5. Shop Apotheke Europe has a total score of 0/6, this is not included on the snowflake, see the detailed checks below.


Note: We use the top 6 management executives and board members in our calculations.

Note 2: Insider trading include any internal stakeholders and these transactions .

Full details on the Management part of the Simply Wall St company analysis model.

News

Simply Wall St News

Company Info

Description

Shop Apotheke Europe N.V. owns and operates online pharmacies in Germany, Austria, Switzerland, Belgium, the Netherlands, France, Italy, and Spain. It provides non-prescription medications, over-the-counter medications, and pharmacy-related beauty and personal care products. The company was founded in 2001 and is headquartered in Venlo, the Netherlands.

Details
Name: Shop Apotheke Europe N.V.
SAED
Exchange: BATS-CHIXE
Founded: 2001
€915,539,420
13,463,815
Website: http://shop-apotheke-europe.com
Address: Shop Apotheke Europe N.V.
Dirk Hartogweg 14,
Venlo,
Limburg, 5928 LV,
Netherlands
Listings
Exchange Symbol Ticker Symbol Security Exchange Country Currency Listed on
XTRA SAE Ordinary Shares XETRA Trading Platform DE EUR 13. Oct 2016
DB SAE Ordinary Shares Deutsche Boerse AG DE EUR 13. Oct 2016
LSE 0RJT Ordinary Shares London Stock Exchange GB EUR 13. Oct 2016
WBAG SHOP Ordinary Shares Wiener Boerse AG AT EUR 13. Oct 2016
BATS-CHIXE SAED Ordinary Shares BATS 'Chi-X Europe' GB EUR 13. Oct 2016
ETLX SAE Ordinary Shares Eurotlx IT EUR 13. Oct 2016
Number of employees
Current staff
Staff numbers
1,011
Shop Apotheke Europe employees.
Industry
Internet and Direct Marketing Retail
Retail
Company Analysis and Financial Data Status
Area Date (UTC time)
Company Analysis updated: 2020/04/07 19:53
End of day share price update: 2020/04/06 00:00
Last estimates confirmation: 2020/04/06
Last earnings filing: 2020/03/17
Last earnings reported: 2019/12/31
Last annual earnings reported: 2019/12/31


All dates and times in UTC. All financial data provided by Standard & Poor’s Capital IQ.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.